Analyst Price Target is $181.11
▲ +31.71% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Agilent Technologies in the last 3 months. The average price target is $181.11, with a high forecast of $195.00 and a low forecast of $169.00. The average price target represents a 31.71% upside from the last price of $137.51.
Current Consensus is
The current consensus among 11 polled investment analysts is to buy stock in Agilent Technologies. This Buy consensus rating has held steady for over two years.
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.